Granulocyte Colony-Stimulating Factor and Neutrophil Alkaline Phosphatase

  1. Toshikazu Ushijima, MD;
  2. Yoshiaki Ohbayashi, MD;
  3. Hiroshi Sato, MD; and
  4. Akio Urabe, MD
  1. Kanto Teishin Hospital
    Tokyo
    , Japan

    Excerpt

    To the Editor: Neutrophil alkaline phosphatase activity sometimes decreases in patients with myelodysplastic syndromes, suggesting a reduced neutrophil function. The number of neutrophils varies in each case, but patients with myelodysplastic syndromes often have various kinds of infections that are probably related to impaired neutrophil function. Recently, recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been produced in large quantities and has been tried as a clinical treatment (1). We have treated a patient with myelodysplastic syndrome by administering rhG-CSF and observed not only an increase in the number of neutrophils but also an increase in the neutrophil alkaline phosphatase score.

    This 100-word excerpt has been provided in the absence of an abstract.

    « Previous | Next Article »Table of Contents